Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Global Bevacizumab Biosimilar Sales Market Report 2016

  • QYR670197
  • 126 Pages
  • September 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Bevacizumab Biosimilar

Revenue, means the sales value of Bevacizumab Biosimilar

This report studies sales (consumption) of Bevacizumab Biosimilar in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Pfizer

Allergan

Alnylam Pharmaceuticals

Amgen

Angstrom Pharmaceuticals

Acceleron Pharma

Biocon

Bionomics

CASI Pharmaceuticals

Celgene Corporation

Enzon Pharmaceuticals

Five Prime Therapeutics

Fujifilm Kyowa Kirin Biologics

Genentech

Genexine

Hetero Drugs

ImClone Systems

Intas Pharmaceuticals

Kyowa Hakko Kirin

Levolta Pharmaceuticals

Mabtech

Marsala Biotech

Neumedicines

Novartis

Oncobiologics

Onyx Pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Bevacizumab Biosimilar in these regions, from 2011 to 2021 (forecast), like

USA

China

Europe

Japan

India

Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Bevacizumab Biosimilar in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Global Bevacizumab Biosimilar Sales Market Report 2016

1 Bevacizumab Biosimilar Overview

1.1 Product Overview and Scope of Bevacizumab Biosimilar

1.2 Classification of Bevacizumab Biosimilar

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Bevacizumab Biosimilar

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Bevacizumab Biosimilar Market by Regions

1.4.1 USA Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Bevacizumab Biosimilar (2011-2021)

1.5.1 Global Bevacizumab Biosimilar Sales and Growth Rate (2011-2021)

1.5.2 Global Bevacizumab Biosimilar Revenue and Growth Rate (2011-2021)

2 Global Bevacizumab Biosimilar Competition by Manufacturers, Type and Application

2.1 Global Bevacizumab Biosimilar Market Competition by Manufacturers

2.1.1 Global Bevacizumab Biosimilar Sales and Market Share of Key Manufacturers (2011-2016)

2.1.2 Global Bevacizumab Biosimilar Revenue and Share by Manufacturers (2011-2016)

2.2 Global Bevacizumab Biosimilar (Volume and Value) by Type

2.2.1 Global Bevacizumab Biosimilar Sales and Market Share by Type (2011-2016)

2.2.2 Global Bevacizumab Biosimilar Revenue and Market Share by Type (2011-2016)

2.3 Global Bevacizumab Biosimilar (Volume and Value) by Regions

2.3.1 Global Bevacizumab Biosimilar Sales and Market Share by Regions (2011-2016)

2.3.2 Global Bevacizumab Biosimilar Revenue and Market Share by Regions (2011-2016)

2.4 Global Bevacizumab Biosimilar (Volume) by Application

3 USA Bevacizumab Biosimilar (Volume, Value and Sales Price)

3.1 USA Bevacizumab Biosimilar Sales and Value (2011-2016)

3.1.1 USA Bevacizumab Biosimilar Sales and Growth Rate (2011-2016)

3.1.2 USA Bevacizumab Biosimilar Revenue and Growth Rate (2011-2016)

3.1.3 USA Bevacizumab Biosimilar Sales Price Trend (2011-2016)

3.2 USA Bevacizumab Biosimilar Sales and Market Share by Manufacturers

3.3 USA Bevacizumab Biosimilar Sales and Market Share by Type

3.4 USA Bevacizumab Biosimilar Sales and Market Share by Application

4 China Bevacizumab Biosimilar (Volume, Value and Sales Price)

4.1 China Bevacizumab Biosimilar Sales and Value (2011-2016)

4.1.1 China Bevacizumab Biosimilar Sales and Growth Rate (2011-2016)

4.1.2 China Bevacizumab Biosimilar Revenue and Growth Rate (2011-2016)

4.1.3 China Bevacizumab Biosimilar Sales Price Trend (2011-2016)

4.2 China Bevacizumab Biosimilar Sales and Market Share by Manufacturers

4.3 China Bevacizumab Biosimilar Sales and Market Share by Type

4.4 China Bevacizumab Biosimilar Sales and Market Share by Application

5 Europe Bevacizumab Biosimilar (Volume, Value and Sales Price)

5.1 Europe Bevacizumab Biosimilar Sales and Value (2011-2016)

5.1.1 Europe Bevacizumab Biosimilar Sales and Growth Rate (2011-2016)

5.1.2 Europe Bevacizumab Biosimilar Revenue and Growth Rate (2011-2016)

5.1.3 Europe Bevacizumab Biosimilar Sales Price Trend (2011-2016)

5.2 Europe Bevacizumab Biosimilar Sales and Market Share by Manufacturers

5.3 Europe Bevacizumab Biosimilar Sales and Market Share by Type

5.4 Europe Bevacizumab Biosimilar Sales and Market Share by Application

6 Japan Bevacizumab Biosimilar (Volume, Value and Sales Price)

6.1 Japan Bevacizumab Biosimilar Sales and Value (2011-2016)

6.1.1 Japan Bevacizumab Biosimilar Sales and Growth Rate (2011-2016)

6.1.2 Japan Bevacizumab Biosimilar Revenue and Growth Rate (2011-2016)

6.1.3 Japan Bevacizumab Biosimilar Sales Price Trend (2011-2016)

6.2 Japan Bevacizumab Biosimilar Sales and Market Share by Manufacturers

6.3 Japan Bevacizumab Biosimilar Sales and Market Share by Type

6.4 Japan Bevacizumab Biosimilar Sales and Market Share by Application

7 India Bevacizumab Biosimilar (Volume, Value and Sales Price)

7.1 India Bevacizumab Biosimilar Sales and Value (2011-2016)

7.1.1 India Bevacizumab Biosimilar Sales and Growth Rate (2011-2016)

7.1.2 India Bevacizumab Biosimilar Revenue and Growth Rate (2011-2016)

7.1.3 India Bevacizumab Biosimilar Sales Price Trend (2011-2016)

7.2 India Bevacizumab Biosimilar Sales and Market Share by Manufacturers

7.3 India Bevacizumab Biosimilar Sales and Market Share by Type

7.4 India Bevacizumab Biosimilar Sales and Market Share by Application

8 Southeast Asia Bevacizumab Biosimilar (Volume, Value and Sales Price)

8.1 Southeast Asia Bevacizumab Biosimilar Sales and Value (2011-2016)

8.1.1 Southeast Asia Bevacizumab Biosimilar Sales and Growth Rate (2011-2016)

8.1.2 Southeast Asia Bevacizumab Biosimilar Revenue and Growth Rate (2011-2016)

8.1.3 Southeast Asia Bevacizumab Biosimilar Sales Price Trend (2011-2016)

8.2 Southeast Asia Bevacizumab Biosimilar Sales and Market Share by Manufacturers

8.3 Southeast Asia Bevacizumab Biosimilar Sales and Market Share by Type

8.4 Southeast Asia Bevacizumab Biosimilar Sales and Market Share by Application

9 Global Bevacizumab Biosimilar Manufacturers Analysis

9.1 Pfizer

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Bevacizumab Biosimilar Product Type, Application and Specification

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Pfizer Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

9.1.4 Main Business/Business Overview

9.2 Allergan

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 126 Product Type, Application and Specification

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Allergan Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

9.2.4 Main Business/Business Overview

9.3 Alnylam Pharmaceuticals

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 147 Product Type, Application and Specification

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Alnylam Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

9.3.4 Main Business/Business Overview

9.4 Amgen

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Aug Product Type, Application and Specification

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 Amgen Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

9.4.4 Main Business/Business Overview

9.5 Angstrom Pharmaceuticals

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Product Type, Application and Specification

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Angstrom Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

9.5.4 Main Business/Business Overview

9.6 Acceleron Pharma

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Million USD Product Type, Application and Specification

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Acceleron Pharma Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

9.6.4 Main Business/Business Overview

9.7 Biocon

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Pharma & Healthcare Product Type, Application and Specification

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Biocon Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

9.7.4 Main Business/Business Overview

9.8 Bionomics

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Product Type, Application and Specification

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Bionomics Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

9.8.4 Main Business/Business Overview

9.9 CASI Pharmaceuticals

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Product Type, Application and Specification

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 CASI Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

9.9.4 Main Business/Business Overview

9.10 Celgene Corporation

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Product Type, Application and Specification

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Celgene Corporation Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

9.10.4 Main Business/Business Overview

9.11 Enzon Pharmaceuticals

9.12 Five Prime Therapeutics

9.13 Fujifilm Kyowa Kirin Biologics

9.14 Genentech

9.15 Genexine

9.16 Hetero Drugs

9.17 ImClone Systems

9.18 Intas Pharmaceuticals

9.19 Kyowa Hakko Kirin

9.20 Levolta Pharmaceuticals

9.21 Mabtech

9.22 Marsala Biotech

9.23 Neumedicines

9.24 Novartis

9.25 Oncobiologics

9.26 Onyx Pharmaceuticals

10 Bevacizumab Biosimilar Maufacturing Cost Analysis

10.1 Bevacizumab Biosimilar Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Bevacizumab Biosimilar

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Bevacizumab Biosimilar Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Bevacizumab Biosimilar Market Forecast (2016-2021)

14.1 Global Bevacizumab Biosimilar Sales, Revenue Forecast (2016-2021)

14.2 Global Bevacizumab Biosimilar Sales Forecast by Regions (2016-2021)

14.3 Global Bevacizumab Biosimilar Sales Forecast by Type (2016-2021)

14.4 Global Bevacizumab Biosimilar Sales Forecast by Application (2016-2021)

15 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Tables and Figures

Figure Picture of Bevacizumab Biosimilar

Table Classification of Bevacizumab Biosimilar

Figure Global Sales Market Share of Bevacizumab Biosimilar by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Applications of Bevacizumab Biosimilar

Figure Global Sales Market Share of Bevacizumab Biosimilar by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure USA Bevacizumab Biosimilar Revenue and Growth Rate (2011-2021)

Figure China Bevacizumab Biosimilar Revenue and Growth Rate (2011-2021)

Figure Europe Bevacizumab Biosimilar Revenue and Growth Rate (2011-2021)

Figure Japan Bevacizumab Biosimilar Revenue and Growth Rate (2011-2021)

Figure India Bevacizumab Biosimilar Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Bevacizumab Biosimilar Revenue and Growth Rate (2011-2021)

Figure Global Bevacizumab Biosimilar Sales and Growth Rate (2011-2021)

Figure Global Bevacizumab Biosimilar Revenue and Growth Rate (2011-2021)

Table Global Bevacizumab Biosimilar Sales of Key Manufacturers (2011-2016)

Table Global Bevacizumab Biosimilar Sales Share by Manufacturers (2011-2016)

Figure 2015 Bevacizumab Biosimilar Sales Share by Manufacturers

Figure 2016 Bevacizumab Biosimilar Sales Share by Manufacturers

Table Global Bevacizumab Biosimilar Revenue by Manufacturers (2011-2016)

Table Global Bevacizumab Biosimilar Revenue Share by Manufacturers (2011-2016)

Table 2015 Global Bevacizumab Biosimilar Revenue Share by Manufacturers

Table 2016 Global Bevacizumab Biosimilar Revenue Share by Manufacturers

Table Global Bevacizumab Biosimilar Sales and Market Share by Type (2011-2016)

Table Global Bevacizumab Biosimilar Sales Share by Type (2011-2016)

Figure Sales Market Share of Bevacizumab Biosimilar by Type (2011-2016)

Figure Global Bevacizumab Biosimilar Sales Growth Rate by Type (2011-2016)

Table Global Bevacizumab Biosimilar Revenue and Market Share by Type (2011-2016)

Table Global Bevacizumab Biosimilar Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Bevacizumab Biosimilar by Type (2011-2016)

Figure Global Bevacizumab Biosimilar Revenue Growth Rate by Type (2011-2016)

Table Global Bevacizumab Biosimilar Sales and Market Share by Regions (2011-2016)

Table Global Bevacizumab Biosimilar Sales Share by Regions (2011-2016)

Figure Sales Market Share of Bevacizumab Biosimilar by Regions (2011-2016)

Figure Global Bevacizumab Biosimilar Sales Growth Rate by Regions (2011-2016)

Table Global Bevacizumab Biosimilar Revenue and Market Share by Regions (2011-2016)

Table Global Bevacizumab Biosimilar Revenue Share by Regions (2011-2016)

Figure Revenue Market Share of Bevacizumab Biosimilar by Regions (2011-2016)

Figure Global Bevacizumab Biosimilar Revenue Growth Rate by Regions (2011-2016)

Table Global Bevacizumab Biosimilar Sales and Market Share by Application (2011-2016)

Table Global Bevacizumab Biosimilar Sales Share by Application (2011-2016)

Figure Sales Market Share of Bevacizumab Biosimilar by Application (2011-2016)

Figure Global Bevacizumab Biosimilar Sales Growth Rate by Application (2011-2016)

Figure USA Bevacizumab Biosimilar Sales and Growth Rate (2011-2016)

Figure USA Bevacizumab Biosimilar Revenue and Growth Rate (2011-2016)

Figure USA Bevacizumab Biosimilar Sales Price Trend (2011-2016)

Table USA Bevacizumab Biosimilar Sales by Manufacturers (2011-2016)

Table USA Bevacizumab Biosimilar Market Share by Manufacturers (2011-2016)

Table USA Bevacizumab Biosimilar Sales by Type (2011-2016)

Table USA Bevacizumab Biosimilar Market Share by Type (2011-2016)

Table USA Bevacizumab Biosimilar Sales by Application (2011-2016)

Table USA Bevacizumab Biosimilar Market Share by Application (2011-2016)

Figure China Bevacizumab Biosimilar Sales and Growth Rate (2011-2016)

Figure China Bevacizumab Biosimilar Revenue and Growth Rate (2011-2016)

Figure China Bevacizumab Biosimilar Sales Price Trend (2011-2016)

Table China Bevacizumab Biosimilar Sales by Manufacturers (2011-2016)

Table China Bevacizumab Biosimilar Market Share by Manufacturers (2011-2016)

Table China Bevacizumab Biosimilar Sales by Type (2011-2016)

Table China Bevacizumab Biosimilar Market Share by Type (2011-2016)

Table China Bevacizumab Biosimilar Sales by Application (2011-2016)

Table China Bevacizumab Biosimilar Market Share by Application (2011-2016)

Figure Europe Bevacizumab Biosimilar Sales and Growth Rate (2011-2016)

Figure Europe Bevacizumab Biosimilar Revenue and Growth Rate (2011-2016)

Figure Europe Bevacizumab Biosimilar Sales Price Trend (2011-2016)

Table Europe Bevacizumab Biosimilar Sales by Manufacturers (2011-2016)

Table Europe Bevacizumab Biosimilar Market Share by Manufacturers (2011-2016)

Table Europe Bevacizumab Biosimilar Sales by Type (2011-2016)

Table Europe Bevacizumab Biosimilar Market Share by Type (2011-2016)

Table Europe Bevacizumab Biosimilar Sales by Application (2011-2016)

Table Europe Bevacizumab Biosimilar Market Share by Application (2011-2016)

Figure Japan Bevacizumab Biosimilar Sales and Growth Rate (2011-2016)

Figure Japan Bevacizumab Biosimilar Revenue and Growth Rate (2011-2016)

Figure Japan Bevacizumab Biosimilar Sales Price Trend (2011-2016)

Table Japan Bevacizumab Biosimilar Sales by Manufacturers (2011-2016)

Table Japan Bevacizumab Biosimilar Market Share by Manufacturers (2011-2016)

Table Japan Bevacizumab Biosimilar Sales by Type (2011-2016)

Table Japan Bevacizumab Biosimilar Market Share by Type (2011-2016)

Table Japan Bevacizumab Biosimilar Sales by Application (2011-2016)

Table Japan Bevacizumab Biosimilar Market Share by Application (2011-2016)

Figure India Bevacizumab Biosimilar Sales and Growth Rate (2011-2016)

Figure India Bevacizumab Biosimilar Revenue and Growth Rate (2011-2016)

Figure India Bevacizumab Biosimilar Sales Price Trend (2011-2016)

Table India Bevacizumab Biosimilar Sales by Manufacturers (2011-2016)

Table India Bevacizumab Biosimilar Market Share by Manufacturers (2011-2016)

Table India Bevacizumab Biosimilar Sales by Type (2011-2016)

Table India Bevacizumab Biosimilar Market Share by Type (2011-2016)

Table India Bevacizumab Biosimilar Sales by Application (2011-2016)

Table India Bevacizumab Biosimilar Market Share by Application (2011-2016)

Figure Southeast Asia Bevacizumab Biosimilar Sales and Growth Rate (2011-2016)

Figure Southeast Asia Bevacizumab Biosimilar Revenue and Growth Rate (2011-2016)

Figure Southeast Asia Bevacizumab Biosimilar Sales Price Trend (2011-2016)

Table Southeast Asia Bevacizumab Biosimilar Sales by Manufacturers (2011-2016)

Table Southeast Asia Bevacizumab Biosimilar Market Share by Manufacturers (2011-2016)

Table Southeast Asia Bevacizumab Biosimilar Sales by Type (2011-2016)

Table Southeast Asia Bevacizumab Biosimilar Market Share by Type (2011-2016)

Table Southeast Asia Bevacizumab Biosimilar Sales by Application (2011-2016)

Table Southeast Asia Bevacizumab Biosimilar Market Share by Application (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Allergan Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Alnylam Pharmaceuticals Basic Information List

Table Alnylam Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Alnylam Pharmaceuticals Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Angstrom Pharmaceuticals Basic Information List

Table Angstrom Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Angstrom Pharmaceuticals Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Acceleron Pharma Basic Information List

Table Acceleron Pharma Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Acceleron Pharma Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Biocon Basic Information List

Table Biocon Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Biocon Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Bionomics Basic Information List

Table Bionomics Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bionomics Bevacizumab Biosimilar Global Market Share (2011-2016)

Table CASI Pharmaceuticals Basic Information List

Table CASI Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure CASI Pharmaceuticals Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Celgene Corporation Basic Information List

Table Celgene Corporation Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Celgene Corporation Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Enzon Pharmaceuticals Basic Information List

Table Enzon Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Enzon Pharmaceuticals Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Five Prime Therapeutics Basic Information List

Table Five Prime Therapeutics Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Five Prime Therapeutics Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Fujifilm Kyowa Kirin Biologics Basic Information List

Table Fujifilm Kyowa Kirin Biologics Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Fujifilm Kyowa Kirin Biologics Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Genentech Basic Information List

Table Genentech Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Genentech Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Genexine Basic Information List

Table Genexine Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Genexine Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Hetero Drugs Basic Information List

Table Hetero Drugs Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Hetero Drugs Bevacizumab Biosimilar Global Market Share (2011-2016)

Table ImClone Systems Basic Information List

Table ImClone Systems Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure ImClone Systems Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Intas Pharmaceuticals Basic Information List

Table Intas Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Intas Pharmaceuticals Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Kyowa Hakko Kirin Basic Information List

Table Kyowa Hakko Kirin Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Kyowa Hakko Kirin Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Levolta Pharmaceuticals Basic Information List

Table Levolta Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Levolta Pharmaceuticals Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Mabtech Basic Information List

Table Mabtech Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Mabtech Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Marsala Biotech Basic Information List

Table Marsala Biotech Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Marsala Biotech Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Neumedicines Basic Information List

Table Neumedicines Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Neumedicines Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Oncobiologics Basic Information List

Table Oncobiologics Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Oncobiologics Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Onyx Pharmaceuticals Basic Information List

Table Onyx Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Onyx Pharmaceuticals Bevacizumab Biosimilar Global Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Bevacizumab Biosimilar

Figure Manufacturing Process Analysis of Bevacizumab Biosimilar

Figure Bevacizumab Biosimilar Industrial Chain Analysis

Table Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2015

Table Major Buyers of Bevacizumab Biosimilar

Table Distributors/Traders List

Figure Global Bevacizumab Biosimilar Sales and Growth Rate Forecast (2016-2021)

Figure Global Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)

Table Global Bevacizumab Biosimilar Sales Forecast by Regions (2016-2021)

Table Global Bevacizumab Biosimilar Sales Forecast by Type (2016-2021)

Table Global Bevacizumab Biosimilar Sales Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750